Literature DB >> 24563434

Subclinical hypercortisol-assessment of bone fragility: experience of single osteoporosis center in Sicily.

A Lasco1, A Catalano, A Pilato, G Basile, A Mallamace, M Atteritano.   

Abstract

AIM: Hypercortisolism is known to cause osteoporosis. Some evidence suggests that osteoporotic fractures may be the presenting manifestations of otherwise-asymptomatic hypercortisolism. The aim of our research was to investigate the prevalence of subclinical hypercortisolism (SH) in postmenopausal women evaluated for bone fragility. PATIENTS AND METHODS: One hundred consecutive postmenopausal women attending the Osteoporosis Centre in the Department of Internal Medicine of the University of Messina (Messina, Italy), for the first time, were screened and a total of 50 patients (age 58±5 years) were studied. Hypercortisolism was diagnosed by unsuppressed serum cortisol levels after 2 day low dose dexamethasone suppression test.
RESULTS: Among the 50 postmenopausal women studied, 3 had SH. This prevalence was 6%. The three patients with SH had a normal bone mineral density (BMD) at lumbar spine and were osteopenic at femoral neck, and presented one or more vertebral fractures at spinal radiography.
CONCLUSIONS: Physicians should always consider SH among the causes of bone fragility, especially in individuals with vertebral fractures and the presence of an only slightly reduced BMD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24563434

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Prevalence of less severe hypercortisolism in fractured patients admitted in an outpatient clinic for metabolic bone diseases.

Authors:  F Pugliese; A S Salcuni; C Battista; V Carnevale; G Guglielmi; C Columbu; F Velluzzi; L Giovanelli; C Eller-Vainicher; A Scillitani; I Chiodini
Journal:  Endocrine       Date:  2021-01-23       Impact factor: 3.633

2.  Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates.

Authors:  Antonino Catalano; Gian Luca Vita; Federica Bellone; Maria Sframeli; Maria Grazia Distefano; Matteo La Rosa; Agostino Gaudio; Giuseppe Vita; Nunziata Morabito; Sonia Messina
Journal:  J Endocrinol Invest       Date:  2021-09-15       Impact factor: 4.256

3.  Circulating MicroRNA Expression, Vitamin D, and Hypercortisolism as Predictors of Osteoporosis in Elderly Postmenopausal Women.

Authors:  Hadeel A Al-Rawaf; Ahmad H Alghadir; Sami A Gabr
Journal:  Dis Markers       Date:  2021-12-13       Impact factor: 3.434

Review 4.  Hidden hypercortisolism: a too frequently neglected clinical condition.

Authors:  L Giovanelli; C Aresta; V Favero; M Bonomi; B Cangiano; C Eller-Vainicher; G Grassi; V Morelli; F Pugliese; A Falchetti; L Gennari; A Scillitani; L Persani; I Chiodini
Journal:  J Endocrinol Invest       Date:  2021-01-04       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.